There are two major publicly traded companies related to "Merck," each with its own stock (Aktie):
- Merck & Co., Inc. (Ticker: MRK), listed on the New York Stock Exchange (NYSE), is a leading U.S.-based pharmaceutical company. As of early October 2025:
- Current stock price is about $89.19 USD.
- Market capitalization is approximately $222.8 billion USD.
- Price-Earnings ratio is around 13.74.
- Dividend yield is roughly 3.14%.
- The stock has seen a 52-week range from $73.31 to around $112.
- The stock is considered "strongly undervalued" by some analysts with positive earnings forecasts through 2028.
- Merck KGaA (Ticker: MKGAF / DE0006599905), a German-based global health, chemical, and life science company listed primarily in Germany:
- Current stock price is about €120.60.
- Market capitalization approximately €51.17 billion.
- Price-Earnings ratio is about 21.9.
- Dividend yield is around 1.57%.
- The company operates in pharma, chemicals, and life sciences with a strong focus on biotech and specialty materials.
Summary table of key stock info:
Company| Ticker| Exchange| Price (local)| Market Cap| P/E Ratio| Dividend
Yield
---|---|---|---|---|---|---
Merck & Co.| MRK| NYSE (USD)| $89.19| $222.8 billion| 13.74| ~3.14%
Merck KGaA| MKGAF| German exchanges| €120.60| €51.17 billion| 21.9| ~1.57%
Both are significant pharmaceutical players but are independent companies with different markets and stock listings. The U.S. Merck & Co. (MRK) is a large- cap pharma stock in the U.S. market, while Merck KGaA is a diversified German life sciences company listed in Europe.
If interested in the performance or investment details of either stock, considering currency, market environment, and regional regulations is important.
